Homocysteine: the new player in the field of coronary risk.
Open Access
- 1 August 1996
- Vol. 76 (2) , 101-102
- https://doi.org/10.1136/hrt.76.2.101
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Hyperhomocysteinemia and Low Pyridoxal PhosphateCirculation, 1995
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Fibrinogen After Coronary Angioplasty as a Risk Factor for RestenosisCirculation, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis, 1994
- Fibrinogen as a Cardiovascular Risk FactorAnnals of Internal Medicine, 1993
- The French Paradox: Dietary Factors and Cigarette Smoking‐Related Health RisksAnnals of the New York Academy of Sciences, 1993
- Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parametersThrombosis Research, 1993